-
Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN CTO RegistryT Hirai, M Qintar, on behalf of the OPEN CTO Study Group et al. -
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance MeasuresJneid H, Addison D, Bhatt DL et al.
-
Spontaneous Coronary Artery Dissection: JACC State-of-the-Art ReviewSN Hayes, MS Tweet, D Adlam et al.
-
Cardiopulmonary Exercise Testing: What Is its Value?Guazzi M, Bandera F, Ozemek C et al.
-
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationNatsumeda M, Florea V, Hare JM et al.
-
Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice : An NCDR Registry to Practice ProjectKatherine Hsin-Yu Chau, MD1,2; Kevin F. Kennedy, ; John C. Messenger, MD4; et al
-
Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and ControversiesTajti P, Brilakis ES.
-
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical TrialGiugliano RP, Keech A, Murphy SA et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
